Literature DB >> 15748081

Field evaluation of latex agglutination test for detecting urinary antigens in visceral leishmaniasis in Sudan.

S H El-Safi1, A Abdel-Haleem, A Hammad, I El-Basha, A Omer, H G Kareem, M Boelaert, M Chance, M Hommel.   

Abstract

A latex agglutination test to detect urinary antigens for visceral leishmaniasis (VL) was studied. In 204 patients with suspected VL, KAtex had a sensitivity of 95.2% with good agreement with microscopy smears but poor agreement with 4 different serology tests. It was also positive in 2 confirmed VL cases co-infected with HIV. In all K4tex-positive confirmed cases actively followed up after treatment, the test became negative 1 month after completion of treatment. While IC4tex had a specificity of 100% in healthy endemic and non-endemic controls, the direct agglutination test (DAT) was positive in 14% of the KAtex-negative healthy endemic controls. KAtex is a simple addition to the diagnostics of VL particularly at field level and as a complementary test for the diagnosis of VL in smear-negative cases with positive DAT results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15748081

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  16 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 2.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

3.  Serological tests for visceral leishmaniasis.

Authors:  Diana N J Lockwood; Shyam Sundar
Journal:  BMJ       Date:  2006-10-07

4.  Use of a newly developed beta-mercaptoethanol enzyme-linked immunosorbent assay to diagnose visceral leishmaniasis in patients in eastern Sudan.

Authors:  Durria Mansour; Elfadil M Abass; Mohamed El Mutasim; Abdelhafeiz Mahamoud; Abdallah El Harith
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

5.  In search of an ideal test for diagnosis and prognosis of kala-azar.

Authors:  Dharmendra P Singh; Rahul K Goyal; Rahul K Singh; S Sundar; Tribhuban M Mohapatra
Journal:  J Health Popul Nutr       Date:  2010-06       Impact factor: 2.000

6.  Improvement of the newly developed latex agglutination test (Katex) for diagnosis of visceral lieshmaniasis.

Authors:  Gholam Reza Hatam; Mohammad Amin Ghatee; Seyed Mohammad Hossein Hossini; Bahador Sarkari
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 7.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Analysis of Total Urine Proteins: Towards A Non-Invasive Approach for Diagnosis of Visceral Leishmaniasis.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  J Mol Biomark Diagn       Date:  2012-08-27

Review 9.  Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease.

Authors:  Marleen Boelaert; Kristien Verdonck; Joris Menten; Temmy Sunyoto; Johan van Griensven; Francois Chappuis; Suman Rijal
Journal:  Cochrane Database Syst Rev       Date:  2014-06-20

10.  Novel Antigen Detection Assay to Monitor Therapeutic Efficacy of Visceral Leishmaniasis.

Authors:  Claudia Abeijon; Om Prakash Singh; Jaya Chakravarty; Shyam Sundar; Antonio Campos-Neto
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.